Clinical

Dataset Information

0

Proof-of-Concept Study in Cancer Patients to Assess Efficacy of Elsiglutide in Preventing Chemotherapy-Induced Diarrhea


ABSTRACT: The main objective of this study will be to obtain data on the efficacy of elsiglutide in preventing Chemotherapy Induced Diarrhea (CID) in patients with colorectal cancer receiving 5-FU based chemotherapy (FOLFOX4 or FOLFIRI regimen) in comparison to placebo.

DISEASE(S): Kemoterápia Okozta Hasmenés,Chemotherapy Induced Diarrhea,Diarrhea Post Chemotherapy,Diarrhea

PROVIDER: 2121148 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2015-12-31 | E-GEOD-69657 | biostudies-arrayexpress
2015-06-04 | E-GEOD-69529 | biostudies-arrayexpress
| 47645 | ecrin-mdr-crc
2022-01-03 | GSE192690 | GEO
2015-12-31 | GSE69657 | GEO
2015-06-04 | GSE69529 | GEO
| S-EPMC7216897 | biostudies-literature
| S-EPMC7273233 | biostudies-literature
2019-09-17 | GSE137470 | GEO
| S-EPMC3157615 | biostudies-literature